• Most Popular
  • Most Shared

FDA cites 62 reports of possible heparin deaths

WASHINGTON
Tue Apr 8, 2008 6:45pm EDT

WASHINGTON (Reuters) - U.S. regulators have received 62 reports of deaths during the last 15 months of patients who were treated with the blood-thinner heparin and suffered allergic reactions or low blood pressure, the Food and Drug Administration said on Tuesday.

Health  |  Stocks  |  Regulatory News  |  Global Markets

Those are the problems that prompted Baxter International Inc to recall most of its heparin products in February.

Baxter spokeswoman Erin Gardiner reiterated that the company believes four deaths may be linked to its version of heparin. APP Pharmaceuticals spokeswoman Maili Bergman said none of the 62 cases cited by the FDA were associated with its brand of the blood thinner.

(Reporting by Lisa Richwine)



More from Reuters

Exclusive: U.S. business investment showing life

CHICAGO (Reuters) - A trade group for the lenders that finance half the capital equipment investment in the United States said on Tuesday the sharp pullback in business borrowing that marked the recent downturn moderated markedly in November -- an encouraging sign companies may be growing more confident in the sustainability of the recovery.

Malaysians participate in computer attack and defence hacking competition during The 3rd Annual Hack-In-The-Box Security Conference 2004 in Kuala Lumpur on October 6, 2004. REUTERS/Bazuki Muhammad
Commentary:

Year of the breach

Data security breaches are nasty business and should be avoided at all costs, writes Kevin Prince, a chief technology officer at Perimeter e-Security. Here's a look at the biggest breaches and blunders of 2009.  Commentary 

Soldiers look on as U.S. Secretary of Defense Robert Gates speaks to soldiers at F.O.B. Warrior in Kirkuk, Iraq December 11, 2009.  REUTERS/Justin Sullivan/Pool

Are you pregnant? Sir! No, Sir!

There are some 115,000 U.S. troops in Iraq -- and one commander wants to make sure his soldiers don't multiply.  Full Article